Strides Pharma acquires Sandoz generics portfolio for ₹111 crore
Strides Pharma announced the acquisition of Sandoz's generics portfolio for $12 million (₹111 crore) to expand in sub-Saharan Africa. CureBay also acquired Saveo Healthtech's pharmaceutical distribution business, strengthening its market presence.
pre-market1 source ↓written by the desknot a recommendation
- sub-Saharan Africa
- $12 million (₹111 crore)
Strides Pharma Science Ltd has agreed to acquire Sandoz AG's branded generic products portfolio in sub-Saharan Africa for $12 million (₹111 crore). This acquisition, expected to close in Q2 FY24, aims to enhance Strides' market reach and unlock cross-selling opportunities across key markets.
Additionally, CureBay has secured a deal to purchase the pharmaceutical distribution business of Saveo Healthtech, further consolidating its position in the healthcare sector.
Not investment advice. For informational purposes only.